diabetes

Dexcom takes no-fingerprick message to people with Type 2 diabetes in new TV ads
Dexcom takes no-fingerprick message to people with Type 2 diabetes in new TV ads
Fierce Pharma
DexCom
DTC advertising
diabetes
type 2 diabetes
blood glucose monitoring
Flag link:
Vivek Ramaswamy’s Metavant hits a brick wall, abandoning a lead program for diabetes. And there’s nothing visible left to see here
Vivek Ramaswamy’s Metavant hits a brick wall, abandoning a lead program for diabetes. And there’s nothing visible left to see here
Endpoints
Metavant
diabetes
Vivek Ramaswamy
imeglimin
Flag link:
Medtronic ‘Smartens’ up Diabetes Offerings with Insulin Pen Launch
Medtronic ‘Smartens’ up Diabetes Offerings with Insulin Pen Launch
Medical Devices and Diagnostics Industry
Medtronic
diabetes
smart insulin
insulin pen
continuous glucose monitoring
devices
Flag link:
Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal
Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal
Reuters
Novo Nordisk
M&A
Emisphere
pill technology
diabetes
Flag link:
Bayer drug shown to slow diabetic kidney disease
Bayer drug shown to slow diabetic kidney disease
NASDAQ
Bayer
clinical trials
diabeteic kidney disease
kidney disease
diabetes
finerenone
Flag link:
Fresenius outlines plans to expand extracorporeal care portfolio to hearts, lungs
Fresenius outlines plans to expand extracorporeal care portfolio to hearts, lungs
Fierce Biotech
diabetes
Fresenius
intensive care
extracorporeal care
dialysis
Flag link:
Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before
Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before
Stat
diabetes
insulin
drug prices
Donald Trump
2020 Presidential election
Flag link:
Poxel posts phase 3 diabetes data ahead of approval decision
Poxel posts phase 3 diabetes data ahead of approval decision
Fierce Biotech
Poxel
diabetes
clinical trials
imeglimin
Japan
Flag link:
Could MiniMed 770G’s Approval Boost Medtronic’s Position in Diabetes?
Could MiniMed 770G’s Approval Boost Medtronic’s Position in Diabetes?
Medical Devices and Diagnostics Industry
diabetes
Medtronic
MiniMed 770G
insulin pumps
Flag link:
Novo launches type 2 diabetes pill in UK after NICE waives review
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharmaforum
Novo Nordisk
UK
type 2 diabetes
diabetes
Rybelsus
semaglutide
NICE
Flag link:
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Center for Biosimilars
Biocon
Mylan
Semglee
generics
insulin
diabetes
biosimilars
Flag link:
ESC 2020 – Farxiga impresses in chronic kidney disease
ESC 2020 – Farxiga impresses in chronic kidney disease
EP Vantage
ESC
Farxiga
chronic kidney disease
diabetes
clinical trials
AstraZeneca
Flag link:
Study: Type 2 Diabetes Treatments May Be More Effective When Combined
Study: Type 2 Diabetes Treatments May Be More Effective When Combined
BioSpace
diabetes
type 2 diabetes
FGF21
GLP-1 agonist
Flag link:
FDA pulls J&J's Invokana boxed warning after reviewing amputation risks—but the sales damage is done
FDA pulls J&J's Invokana boxed warning after reviewing amputation risks—but the sales damage is done
Fierce Pharma
JNJ
Invokana
diabetes
amputation
black box
Flag link:
Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes
Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes
Pharmaforum
Novo Nordisk
diabetes
digital pharma
digital medicine
Flag link:
25% of diabetes patients rationing treatments amid pandemic, survey finds
25% of diabetes patients rationing treatments amid pandemic, survey finds
Beckers Hospital Review
diabetes
pandemic
COVID-19
patients
Flag link:
Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure
Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure
BioSpace
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
diabetes
clinical trials
Flag link:
Drug lobby sues Minnesota over insulin-pricing law
Drug lobby sues Minnesota over insulin-pricing law
Beckers Hospital Review
Minnesota
regulatory
insulin
drug pricing
diabetes
PhRMA
Flag link:
FDA urged to increase safety warnings on common diabetes drug
FDA urged to increase safety warnings on common diabetes drug
Beckers Hospital Review
Public Citizen
diabetes
citizen petitions
SGLT2 inhibitor
type 1 diabetes
Flag link:
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Fierce Pharma
Mylan
patents
generics
Novo Nordisk
Victoza
diabetes
Flag link:

Pages